The present invention relates to a preoperative planning system and, more particularly, to a system of preoperative planning and provision of patient-specific surgical aids.
The scapula, commonly known as the “shoulder blade”, is a flat, triangular bone that lies over the back of the upper ribs. A right scapula 100 is depicted in posterior, anterior, and right side views in
For treatment of various problems with the shoulder, hip, or other body joint or bone (such as degenerative arthritis and/or traumatic injury), one method of providing relief to a patient is to replace the articulating surfaces with an artificial or prosthetic joint. In the case of a shoulder, the humerus and glenoid vault 110 articulating surfaces are replaced. In the case of a hip, the femur and acetabulum articulating surfaces can be replaced. Both of these examples are of ball-and-socket type joints. Hinge-type joints, such as the knee or elbow, and static/fixed skeletal components, such as the long bones of the arm or leg, as well as interfaces such as those between spinal vertebrae and intervertebral discs, could also be subject to replacement and/or repair by the implantation of artificial or prosthetic components or other fixation devices related to the treatment of fractures, the sequelae of trauma, congenital pathology, or other issues causing a lack of ideal function. For clarity of description, the subject application will be hereafter described as the rehabilitation and/or replacement of a patient's shoulder joint.
In such surgical procedures, pain relief, increased motion, and/or anatomic reconstruction of the joint are goals of the orthopedic surgeon. With multiple variations in human anatomy, prosthetic systems must be carefully designed, chosen, and implanted to accurately replicate the joints that they replace or the bone structures that they aim to change (in any manner).
A shoulder replacement procedure may involve a partial shoulder replacement (not shown) or the total shoulder replacement shown in
Standard prosthetic glenoid components 216 are available in a number of different sizes and configurations. However, most are designed for use in an scapula having minimal bone loss or deformity. When the scapula has bone loss and/or significant pathology due to disease or trauma, the standard glenoid component 216 may be difficult to implant and/or may not enable desired shoulder function, if it cannot be implanted in a preferred manner. The surgeon may thus need to substantially modify the patient's glenoid vault 110 during surgery in an attempt to make the standard glenoid component 216 fit into the glenoid vault. Pre-surgical planning tools are available to help the surgeon anticipate the changes which will be needed to reform the patient's pathological anatomy. However, the surgeon cannot always readily determine whether even a remodeled glenoid vault 110 will fit as desired with a standard prosthesis because the surgeon does not know how a “normal” glenoid vault 110 (for which the standard prosthesis is designed) should be shaped for that patient.
It is known to use computer aided design (“CAD”) software to design custom prostheses based upon imported data obtained from a computerized tomography (“CT”) scan of a patient's body. For example, mirror-imaged CT data of a patient's contralateral “normal” joint could be used, if the contralateral joint does not also display a pathological anatomy. However, using a unique prosthesis design for each patient can result in future biomechanical problems resulting from a non-proven design and takes away the familiarity that the surgeon will likely have with standardized prosthesis designs. Thus, prosthesis designs that are entirely customized are considered sub-optimal solutions.
Further, detailed preoperative planning, using two- or three-dimensional images of the shoulder joint, often assists the surgeon in compensating for the patient's anatomical limitations. During the surgery, for example, an elongated pin may be inserted into the surface of the patient's bone, at a predetermined trajectory and location, to act as a passive landmark or active guiding structure in carrying out the preoperatively planned implantation. This “guide pin” may remain as a portion of the implanted prosthetic joint or may be removed before the surgery is concluded. This type of pin-guided installation is common in any joint replacement procedure—indeed, in any type of surgical procedure in which a surgeon-placed fixed landmark is desirable.
In addition, and again in any type of surgical procedure, modern minimally invasive surgical techniques may dictate that only a small portion of the bone or other tissue surface being operated upon is visible to the surgeon. Depending upon the patient's particular anatomy, the surgeon may not be able to precisely determine the location of the exposed area relative to the remaining, obscured portions of the bone through mere visual observation. For example, in a shoulder surgery, the scapula 100 is mobile along the chest wall and it therefore may be difficult to define the fixed relationship of the glenoid vault 110 to the body of the scapula 100 (i.e., using the plane of the scapula as a reference to the glenoid vault) and/or the body of the scapula to an external coordinate system in the operating room. These factors, particularly in a minimally invasive surgical procedure, may make it difficult for the surgeon to orient the glenoid vault during surgery. Again, a guide pin may be temporarily or permanently placed into the exposed bone surface to help orient the surgeon and thereby enhance the accuracy and efficiency of the surgical procedure.
One goal of shoulder surgery may be to modify the pathologic bone to correct pathologic version to be within the normal range or the normal version of the patient's native anatomy before the bone loss occurred. During surgery, and particularly minimally invasive procedures, the plane of the scapula may be difficult or impossible to determine by direct visual inspection, resulting in the need for assistive devices or methods to define both the pathologic version present at the time of surgery and the intended correction angle.
It is generally believed that there is a preferred orientation for the glenoid component 216 to provide a full range of motion and to minimize the risk of dislocation. Some example orientations of the glenoid component 216 relative to the glenoid face are about 5.degree. of anteversion to about 15.degree. of retroversion; average version is about 1-2.degree. of retroversion. This broadly replicates the natural angle of the glenoid. However, the specific angular orientation of the glenoid portion varies from patient to patient.
With a view to overcoming these and other disadvantages, some arrangements have been recently suggested in which a three-dimensional intraoperative surgical navigation system is used to render a model of the patient's bone structure. This model is displayed on a computer screen and the user is provided with intraoperative three-dimensional information as to the desired positioning of the instruments and the glenoid component 216 of the prosthetic implant. However, surgical navigation arrangements of this type are not wholly satisfactory since they generally use only a low number of measured landmark points to register the patient's anatomy and to specify the angle of the prosthetic implant component (e.g., a glenoid component 216), which may not provide the desired level of accuracy. Further, the information provided by such systems may be difficult to interpret and may even provide the user with a false sense of security. Moreover, these systems are generally expensive to install and operate and also have high user training costs.
Various proposals for trial prosthetic joint components have been made in an attempt to overcome the problems associated with accurately locating the glenoid component 216 of the prosthetic implant. While these trial systems may help with checking whether the selected position is correct, they are not well-suited to specify the correct position initially, and thus there still is user desire for a system which may assist a user in placement of prosthetic implant component in a prepared native tissue site.
Finally, due to factors such as the high cost of operating room time and the patient detriment sometimes posed by lengthy surgeries, the surgeon or other user may wish to simulate a surgical procedure during preoperative planning, in order to become familiar with the tasks that will be required and possibly reduce the time and/or actions needed to perform the surgery.
In summary, preoperative planning and/or simulation, regardless of the planning tasks undertaken or the nature of the changes to be made to the patient's native tissue, will generally reduce the need for intraoperative imaging in most surgical procedures and should result in decreased operative time and increased positional accuracy, all of which are desirable in striving toward a positive patient outcome.
In an embodiment of the present invention, a method of preoperative planning, the method comprises: creating a virtual model of a native patient tissue; placing a virtual device into a desired device orientation relative to the virtual model of the native patient tissue; specifying at least one structural change to the native patient tissue to facilitate placement of the virtual device in the desired device orientation; creating a virtual model of an altered patient tissue responsive to the specifying at least one structural change to the native patient tissue; and fabricating a tangible representation of a bone using the virtual model of the altered patient tissue.
In an embodiment of the present invention, a method of preoperative planning and provision of patient-specific surgical aids is described. A device for placement in engagement with a native patient tissue is chosen. A predetermined device orientation for the device with respect to the native patient tissue is virtually specified. At least one landmark is virtually placed in a predetermined landmark orientation with respect to the predetermined device orientation. A patient-specific placement guide is virtually modeled, the patient-specific placement guide being simultaneously mated with the device and registered with at least one landmark when the device is in the predetermined device orientation. A patient-specific template is virtually modeled, the patient-specific template being configured to mate with the native patient tissue, the patient-specific template having a landmark guiding feature configured to place the landmark in the predetermined landmark orientation when the patient-specific template is mated with the native patient tissue. A physical version of the patient-specific placement guide is created. A physical version of the patient-specific template is created.
In an embodiment of the present invention, a computer readable medium is described. The computer readable medium has computer executable instructions for receiving scanned image data based on an imaging scan of a native patient tissue. An image of the native patient tissue based on the received scanned image data is displayed. Placement of an image of a selected device is displayed over the image of the native patient tissue. The image of the selected device over the image of the native patient tissue is reoriented into a predetermined device orientation. Placement of an image of at least one selected landmark is displayed in a predetermined landmark orientation over the image of the native patient tissue. Placement of an image of a selected guide blank is displayed in a predetermined guide orientation over the image of the native patient tissue and the image of the selected device, when the image of the selected device is in the predetermined device orientation. The selected guide blank is provided with at least one orienting feature, the provided orienting feature being registered with at least one selected landmark when the image of a selected guide blank is in the predetermined guide orientation and the image of the selected device is in the predetermined device orientation. A physical guide is fabricated from the selected guide blank having the provided orienting feature.
In an embodiment of the present invention, a method of preoperative planning and provision of at least one patient-specific surgical aid is described. A virtual model of a native patient tissue is created. A physical model of the native patient tissue as a tangible representation of the virtual model of the native patient tissue is created. The physical model of the native patient tissue includes at least one information feature providing clinically useful information to the user.
For a better understanding of the invention, reference may be made to the accompanying drawings, in which:
The patient tissue is shown and described herein at least as a scapula 100 and the prosthetic implant component is shown and described herein at least as a glenoid component 216, but the patient tissue and corresponding prosthetic implant component could be any desired types such as, but not limited to, hip joints, shoulder joints, knee joints, ankle joints, phalangeal joints, metatarsal joints, spinal structures, long bones (e.g., fracture sites), or any other suitable patient tissue use environment for the present invention. For example, the prosthetic implant component could be an internal fixation device (e.g., a bone plate), a structure of a replacement/prosthetic joint, or any other suitable artificial device to replace or augment a missing or impaired part of the body.
The term “lateral” is used herein to refer to a direction indicated by directional arrow 118 in
In accordance with the present invention,
The virtual model of the native patient tissue may be based upon, for example, scanned image data taken from an imaging scan of the native patient tissue. The term “model” is used herein to indicate a replica or copy of a physical item, at any relative scale and represented in any medium, physical or virtual. The patient tissue model may be a total or partial model of a subject patient tissue, and may be created in any suitable manner. For example, and as presumed in the below description, the patient tissue model may be based upon computer tomography (“CT”) data imported into a computer aided drafting (“CAD”) system. Additionally or alternatively, the native patient tissue model may be based upon digital or analog radiography, magnetic resonance imaging, or any other suitable imaging means. The patient tissue model will generally be displayed for the user to review and manipulate preoperatively, such as through the use of a computer or other graphical workstation interface. While this description presumes a three-dimensional model, one of ordinary skill in the art could use a two-dimensional model in a similar manner to that shown and described herein, without harm to the present invention. An example of a virtual model of the native patient tissue is the native patient tissue model 422 shown in
During preoperative planning with a system such as that described, the user can view the native patient tissue model 422 and, based upon knowledge of other patient characteristics (such as, but not limited to, height, weight, age, and activity level), choose a desired device, described hereafter as a stock device 424, for use in the surgical procedure. This use may include placement in engagement with a native patient tissue model 422, as shown in second action block 326 of
A desired device could be the depicted stock prosthetic implant, a custom prosthetic implant, a stock or custom instrument (not shown), or any other desired item. Because three-dimensional image models are available of many instruments and prosthetic implants, whether stock or custom, the user may be able to “install” the instrument or prosthetic implant virtually in the native patient tissue model 422 via the preoperative computer simulation described herein. During such a simulation, the user can automatically and/or manually adjust or reorient the position of the virtual stock device 424 with respect to the virtual native patient tissue model 422, even to the extent of simulating the dynamic interaction between the two, as may be helpful to refine the selection, placement, and orientation of the stock device for a desired patient outcome. The stock device 422 may be chosen from a library of available stock devices, with the choice based upon any factor or characteristic desired.
The term “stock” is used herein to indicate that the component indicated is not custom-manufactured or -configured for the patient, but is instead provided as a standard inventory item by a manufacturer. A particular stock component may be selected automatically by the system and/or manually by the user from a product line range (e.g., the aforementioned library) of available components, optionally with the user specifying a desired configuration, general or particular size (e.g., small, medium, large, or a specific measurement), material, or any other characteristic of the component. Indeed, the stock component could be manufactured only after the user has selected the desired options from the range of choices available. However, the stock component is differentiated from a custom-manufactured or bespoke component in that the stock component is agnostic and indifferent regarding a particular patient anatomy during the design and manufacturing processes for an instrument, prosthetic implant, or other component intended for that patient, while the patient anatomy is an input into at least one design and/or manufacturing process for a custom-manufactured component. The following description presumes the use of a stock prosthetic implant and stock instrument, though one of ordinary skill in the art will be able to provide for the use of the present invention with a custom-manufactured prosthetic implant or instrument, instead.
At third action block 328 of
The system may place the stock device 424 into the predetermined device orientation automatically by the system and/or manually by the user, based upon any suitable criteria. For example, the system may provide at least two optional device orientations and compare the optional device orientations to each other based upon any desired device property(ies), in a weighted or unweighted manner. Device properties that could factor into the comparison include at least one of device size, device shape, device material, number of fasteners to be used, type of fasteners, size of fasteners, shape of fasteners, amount of patient tissue alteration, type of patient tissue alteration, orientation of the stock device relative to an other stock device (e.g., orientation of one part of a prosthetic joint relative to another part of the prosthetic joint which has already been [virtually] placed with respect to the native patient tissue model), and physical quality of the native patient tissue. A plurality of optional device orientations could be compared to one another based on these or any other suitable factors, in any suitable manner (e.g., using a decision algorithm or comparison scheme). It is contemplated that certain device properties may be more important than others, and that the comparisons will be made automatically by the system and/or manually by the user to allow for compromises—if needed—on certain device properties in order to strive for a better overall outcome.
Once the comparison(s) is (are) made, the user and/or system chooses an optional device orientation based upon the comparison and designates the chosen optional device orientation as the predetermined device orientation. The predetermined device orientation of the stock device 424 with respect to the native patient tissue model 422 is shown in the
Once a chosen stock device 424 has been virtually placed in a desired orientation with respect to the native patient tissue model 422 (it will be understood that some mechanical modification might need to be made to the actual native patient tissue to accomplish this implant placement in situ), the placement of any fasteners or other penetrating structures 430 (e.g., a drill, guide pin, or other surgical tool), when present, may also be planned through the use of the computer simulation. Consideration of the location, amount, and pathology of the patient tissue, any of the above device properties, or any other desired factors, may be taken into account in this optional penetrating structure 430 planning. The penetrating structure(s) 430 may be chosen from a library of available penetrating structures.
Manually and/or with automatic computer assistance, the user can experiment with various fastener sizes, placements, and orientations for securing the stock prosthetic implant to the patient tissue, and/or with various other types of penetrating structure 430 insertions into the native patient tissue model 422 similarly to the previously described device placement, until reaching at least one predetermined penetration orientation (such as that shown in
Once the predetermined device orientation and any desired predetermined penetration orientation(s), when present, are known, the displayed images of the selected stock device 424 and/or of any included penetrating structures 430 may be removed from the displayed image of the native patient tissue model 422, for greater clarity in following portion(s) of the preoperative planning system. The displayed images of the selected stock device 424 and/or of any included penetrating structures 430 may be reinstated and re-removed, as desired, during any phase of the below operations.
As shown in fifth action block 336 of
Regardless of the number, location, type, or any other characteristics of the provided landmark(s) 538, it is contemplated that the user will want to transfer the landmarked information to the actual patient tissue during the surgical procedure. To that end, a patient-specific template may be created using the system described herein. The landmark 538 could also or instead be placed during the surgical procedure using a robotic surgical aid, adjustable reusable (e.g., “dial-in”) tools, intraoperative imaging, or any other suitable placement aid.
As shown at sixth action block 342 of
As is particularly apparent in the coronal (top right) and transverse (bottom right) portions of
The mating surface 748 may be seen in particularly the coronal (top right) and transverse (bottom right) portions of
Regardless of its nature, the patient-specific template 750 virtually contains or embodies at least one predetermined landmark orientation and has at least one landmark guiding feature 752 configured to place a landmark 538 in the predetermined landmark orientation when the patient-specific template 750 is mated with the native tissue model 422. As shown in
When the landmark 538 is a two-dimensional landmark such as a marking on the surface of the native patient tissue, the target trajectory 434 of the landmark guiding feature 752 will likely be of little to no import. In contrast, when the landmark 538 is a three-dimensional landmark such as a drilled hole or an elongate guide pin, the target trajectory 434 of the landmark may bear some significance. In
Once the landmark(s) 538 have been virtually placed into the predetermined landmark orientation(s) at fifth action block 336 of
The patient-specific placement guide 958 may be, for example, similar to any of those disclosed in co-pending U.S. patent application No. to be determined, filed Oct. 27, 2011, titled “System and Method for Assisting with Attachment of a Stock Implant to a Patient Tissue” and claiming priority to U.S. Provisional Patent Application No. 61/408,324, filed Oct. 29, 2010 and titled “System and Method for Assisting with Attachment of a Stock Implant to a Patient Tissue”, the entire contents of both of which are incorporated herein by reference, or in co-pending U.S. patent application No. to be determined, filed Oct. 27, 2011, titled “System and Method for Assisting with Attachment of a Stock Instrument to a Patient Tissue” and claiming priority to U.S. Provisional Patent Application No. 61/408,376, filed Oct. 29, 2010 and titled “System and Method for Assisting with Attachment of a Stock Instrument to a Patient Tissue”, the entire contents of both of which are incorporated herein by reference.
Regardless of the type of patient-specific placement guide 958 provided, the patient-specific placement guide may be generated similarly to the patient-specific template 750. Namely, a placement guide blank 854, shown in
The placement guide blank 854, once selected by any suitable procedure, may then be (virtually) altered to register with at least one landmark 538, as shown in
As another example, and as shown in
In addition to the guiding/orienting function provided by the patient-specific placement guide 958, at least one penetration-guiding feature 962 (four shown in
Once the patient-specific template 750 and/or the patient-specific placement guide 958 have been generated as desired, including any desired features as described above, a physical version of the patient-specific template is created at eighth action block 364 of
Optionally, and as shown in tenth action block 368 of
In one example embodiment of a physical native tissue model giving spatial information, for instance, a planar face bounding a lower portion of the physical native tissue model may be substantially parallel to a transverse plane of the scapula 100. Often the patient is oriented during surgery such that the plane of the scapula 100 is not identifiable with reference to the orientation of the glenoid vault 110 in the surgical field. Accordingly, by placing the physical native tissue model with an information feature in a known position (e.g, by placing a lower face of the physical native tissue model flat on a table), one of ordinary skill in the art can readily envision obscured portions of the patient's native tissue anatomy through reference to the physical native tissue model, which may be configured to provide the user with a visualization of the native patient tissue in the same orientation as in the patient's body but without the surrounding tissue that prevents the user from directly seeing structures such as, but not limited to, the acromion process 106, the coracoid process 108, or any other structure of the scapula 100. This may be particularly useful when the physical native tissue model is fabricated at a 1:1 scale with the native patient anatomy, but also will have utility when the model is scaled up or down from the patient's actual tissue.
As another example embodiment of a physical native tissue model giving spatial information, a pin-receiving aperture may be provided in the physical native tissue model, to receive a guide pin and thus demonstrate a certain direction or axis to the user with respect to the native tissue. As a corollary to this example, an axis-, direction-, or plane-indicating structure may extend from the physical native tissue model to serve as a user visualization aid or reference.
The physical native tissue model could be used to interact with an implant or instrument before or during the surgical procedure, as well. For example, a user could rehearse certain interactions of an implant or instrument with the physical native tissue model to gain familiarity with the way that the implant or instrument is likely to intraoperatively interact with the patient's native tissue.
Physical native tissue models with information features or specific landmarks related to the preoperatively developed surgical plan are not currently provided or used as references during surgical procedures. The availability of a physical native tissue model to use as a reference in this manner may supplement or even supplant the need for intraoperative imaging, which is likely to reduce cost, operating room clutter, and time required for the surgical procedure.
The patient's name, identification number, surgeon's name, and/or any other desired identifier may be molded into, printed on, attached to, or otherwise associated with the physical version(s) of the patient-specific template 750, the patient-specific placement guide 958, and/or the native patient tissue model 422 in a legible manner. The tangible representations of the patient-specific template 750, the patient-specific placement guide 958, and/or the native patient tissue model 422 may be made by any suitable method such as, but not limited to, selective laser sintering (“SLS”), fused deposition modeling (“FDM”), stereolithography (“SLA”), laminated object manufacturing (“LOM”), electron beam melting (“EBM”), 3-dimensional printing (“3DP”), contour milling from a suitable material, computer numeric control (“CNC”), other rapid prototyping methods, or any other desired manufacturing process.
Once the physical versions of the patient-specific template 750, the patient-specific placement guide 958, and/or the native patient tissue model 422 have been manufactured and prepared for use (e.g., mechanically or chemically cleaned, cured, sterilized, or the like) using any suitable process(es), they are available for use during surgical procedures as described above and in the incorporated references.
The preoperative planning system disclosed herein allows the user to experiment with different placements and selections of stock devices 424 and/or custom or patient-specific components in an effort to produce positive patient outcomes.
The goal of arthroplasty surgery is to correct pathologic anatomy and restore as best as possible normal anatomy and function. Corrective options range between placing an implant component at the standard ideal of perpendicular to the plane of the scapula (0.degree.) up to the pathologic version (in this case, 26.degree. of retroversion). Common practice today is to correct version with an attempt to place a stock device 424 approximately perpendicular to the scapular plane 1170 (i.e., lying along the reference plane 1172 at about 0.degree. of version). For clarity of description, the “angle” of the stock device 424 is referenced hereafter as being the angle measured from a top face of the stock device, the top face being foremost in the perspective view of
There normally will be a secondary surgical goals to minimize removal of patient tissue needed to accommodate the stock device 424, seat the entire stock device on the prepared patient tissue surface, and minimize unwanted perforation of the outer walls of the glenoid vault 110 or other patient tissue by the device shaft 540 or another penetrating structure 430 used in the surgical procedure or remaining in the patient tissue postoperatively. When formulating a preoperative plan, typical items of concern include the bone (or other patient tissue) loss in the patient, the position and orientation of the normal joint line, and where the stock device 424 or other component should be placed to aim toward a positive patient outcome.
The present inventors have found that an average patient tissue model 1176 (e.g., a “vault model”) may be useful in tailoring a surgical procedure to fit the needs of an individual patient. A suitable average patient tissue model 1176 is described in co-pending U.S. patent application Ser. No. 12/043,634, filed Mar. 6, 2008, and titled “Method and Apparatus for Preparing for a Surgical Procedure”, the contents of which are hereby incorporated by reference in their entirety. In a similar manner, the shape of an average acetabular vault may be used as a suitable average patient tissue model and have some clinical relevance when defining the normal anatomic relationships from the pathologic anatomy in a hip use environment. The average patient tissue model 1176 of a glenoid vault 110 is shown superimposed on the native patient tissue model 422 in
When planning a surgical procedure using preoperative imaging, the user may specify at least one structural change to the native patient tissue to facilitate placement of a stock device in a predetermined device orientation. For example, native patient tissue could be drilled, planed, reamed or otherwise removed, or the native patient tissue could be built up using bone grafts or other substances, with the latter being much more difficult to do than the former during a standard surgical procedure. Using the system described above, a (virtual) altered patient tissue model (not shown) can be generated and viewed or otherwise used in the preoperative planning. Optionally, a physical three-dimensional version of the altered patient tissue model may be fabricated as a tangible representation of the virtual version of the altered patient tissue model. When provided, the physical altered patient tissue model may also include at least one information feature providing clinically useful information to the user. For example, a landmark 538 (e.g., a cavity or aperture) may be present in the physical altered patient tissue model and may therefore be made palpable to the user during the surgical procedure. The physical altered patient tissue model, when present, may be used and referenced similarly to the aforementioned physical native patient tissue model.
It is apparent from
This problematic 0.degree. version correction is an example of a value taken from a standard reference patient tissue—many users will routinely correct version in all such cases to 0.degree. as shown. As an example of a value range taken from a standard reference patient tissue, the version may be corrected to a value taken from the range of −5.degree. to +5.degree., with the user's experience and intuition leading to the selection of one value from that range. Another example, in a hip standard reference patient tissue, might prescribe a range of 10-30.degree. of anteversion and 30-55.degree. of abduction for an acetabular prosthetic implantation. However, a seemingly reasonable value based upon a standard reference patient tissue—whether for a shoulder, hip, or any other type of surgery—may markedly depart from a value which leads to an acceptable result for a particular patient.
As a result, users will sometimes employ a mirror image of a contralateral native patient tissue (from that patient or another patient) to use as a reference patient tissue. However, even if there is a contralateral native patient tissue to consult (e.g., the patient is not an amputee in that respect), the contralateral native patient tissue may be pathologically or congenitally asymmetrical from even the original state of the native patient tissue which is being surgically corrected. Thus, there is a need for another reference patient tissue for comparison to the native patient tissue model 422.
In the aforementioned co-pending “Method and Apparatus for Preparing for a Surgical Procedure” U.S. patent application, the average patient tissue model 1176 (i.e., the “vault model”) is proposed as providing an appropriate reference patient tissue for a wide range of patients. The average patient tissue model 1176 is shown in
In the situation of
The views of the combination of the altered glenoid vault 110 plus the stock device 424a of
The computer system 1582 includes a processor 1584 and a system memory 1586. Dual microprocessors and other multi-processor architectures can also be utilized as the processor 1584. The processor 1584 and system memory 1586 can be coupled by any of several types of bus structures, including a memory bus or memory controller, a peripheral bus, and a local bus using any of a variety of bus architectures. The system memory 1586 includes read only memory (ROM) 1588 and random access memory (RAM) 1590. A basic input/output system (BIOS) can reside in the ROM 1588, generally containing the basic routines that help to transfer information between elements within the computer system 1582, such as a reset or power-up.
The computer system 1582 can include one or more types of long-term data storage 1592, including a hard disk drive, a magnetic disk drive, (e.g., to read from or write to a removable disk), and an optical disk drive, (e.g., for reading a CD-ROM or DVD disk or to read from or write to other optical media). The long-term data storage 1592 can be connected to the processor 1584 by a drive interface 1594. The long-term data storage 1592 components provide nonvolatile storage of data, data structures, and computer-executable instructions for the computer system 1582. A number of program modules may also be stored in one or more of the drives as well as in the RAM 1590, including an operating system, one or more application programs, other program modules, and program data.
A user may enter commands and information into the computer system 1582 through one or more input devices 1596, such as a keyboard or a pointing device (e.g., a mouse). These and other input devices are often connected to the processor 1584 through a device interface 1598. For example, the input devices can be connected to the system bus by one or more a parallel port, a serial port or a universal serial bus (USB). One or more output device(s) 15100, such as a visual display device or printer, can also be connected to the processor 1584 via the device interface 1598.
The computer system 1582 may operate in a networked environment using logical connections (e.g., a local area network (LAN) or wide area network (WAN) to one or more remote computers 15102. A given remote computer 15102 may be a workstation, a computer system, a router, a peer device or other common network node, and typically includes many or all of the elements described relative to the computer system 1582. The computer system 1582 can communicate with the remote computers 15102 via a network interface 15104, such as a wired or wireless network interface card or modem. In a networked environment, application programs and program data depicted relative to the computer system 1582, or portions thereof, may be stored in memory associated with the remote computers 15102.
It is contemplated that multiple versions of the patient-specific template 750 and/or the patient-specific placement guide 958 could be created during preoperative planning and fabricated as options for the user to select from during the surgical procedure. For example, the user may not be able to clear away surrounding (e.g., soft) tissue from the native patient tissue as well as expected. In this situation, it may be useful to have a patient-specific template 750 with a smaller footprint for easier insertion into the surgical wound and manipulation at the surgical site, even though the smaller footprint means that there is less mating surface 748 to mate with the native patient tissue and provide positive location assistance for the patient-specific template 750.
While aspects of the present invention have been particularly shown and described with reference to the preferred embodiment above, it will be understood by those of ordinary skill in the art that various additional embodiments may be contemplated without departing from the spirit and scope of the present invention. For example, the specific methods described above for using the described system are merely illustrative; one of ordinary skill in the art could readily determine any number of tools, sequences of steps, or other means/options for virtually or actually placing the above-described apparatus, or components thereof, into positions substantially similar to those shown and described herein. Any of the described structures and components could be integrally formed as a single piece or made up of separate sub-components, with either of these formations involving any suitable stock or bespoke components and/or any suitable material or combinations of materials; however, the chosen material(s) should be biocompatible for most applications of the present invention. The mating relationships formed between the described structures need not keep the entirety of each of the “mating” surfaces in direct contact with each other but could include spacers or holdaways for partial direct contact, a liner or other intermediate member for indirect contact, or could even be approximated with intervening space remaining therebetween and no contact. Though certain components described herein are shown as having specific geometric shapes, all structures of the present invention may have any suitable shapes, sizes, configurations, relative relationships, cross-sectional areas, or any other physical characteristics as desirable for a particular application of the present invention. An adhesive (such as, but not limited to, bone cement) could be used in conjunction with the system and method described herein. The patient-specific template 750 and/or the patient-specific placement guide 958 may include a plurality of structures cooperatively forming the base body and temporarily or permanently attached together in such a manner as to permit relative motion (e.g., pivoting, sliding, or any other motion) therebetween. The patient-specific placement guide 958 may not actually be patient-specific but could instead be a stock item in situations where the landmark(s) 538 are placed to “standardize” a particular native patient tissue model with a standard frame of reference. Any structures or features described with reference to one embodiment or configuration of the present invention could be provided, singly or in combination with other structures or features, to any other embodiment or configuration, as it would be impractical to describe each of the embodiments and configurations discussed herein as having all of the options discussed with respect to all of the other embodiments and configurations. Any of the components described herein could have a surface treatment (e.g., texturization, notching, etc.), material choice, and/or other characteristic chosen to provide the component with a desired interaction property (e.g., tissue ingrowth, eluting of a therapeutic material, etc.) with the surrounding tissue. The system is described herein as being used to plan and/or simulate a surgical procedure of implanting one or more prosthetic structures into a patient's body, but also or instead could be used to plan and/or simulate any surgical procedure, regardless of whether a non-native component is left in the patient's body after the procedure. A device or method incorporating any of these features should be understood to fall under the scope of the present invention as determined based upon the claims below and any equivalents thereof.
Other aspects, objects, and advantages of the present invention can be obtained from a study of the drawings, the disclosure, and the appended claims.
The present application is a continuation of U.S. Non-Provisional application Ser. No. 13/282,550 filed on Oct. 27, 2011 which claims priority on U.S. Provisional Application Ser. No. 61/408,392, filed on Oct. 29, 2010, and incorporated herewith by reference.
Number | Name | Date | Kind |
---|---|---|---|
4841975 | Woolson | Jun 1989 | A |
4976737 | Leake | Dec 1990 | A |
5098383 | Hemmy | Mar 1992 | A |
5250050 | Poggie | Oct 1993 | A |
5490854 | Fisher et al. | Feb 1996 | A |
5682886 | Delp et al. | Nov 1997 | A |
5768134 | Swaelens et al. | Jun 1998 | A |
5871018 | Delp et al. | Feb 1999 | A |
5916219 | Matsuno et al. | Jun 1999 | A |
6205411 | DiGioia, III et al. | Mar 2001 | B1 |
6327491 | Franklin | Dec 2001 | B1 |
6711432 | Krause et al. | Mar 2004 | B1 |
6772026 | Bradbury et al. | Aug 2004 | B2 |
7194120 | Wicker et al. | Mar 2007 | B2 |
7357057 | Chiang | Apr 2008 | B2 |
7468075 | Lang et al. | Dec 2008 | B2 |
7510557 | Bonutti | Mar 2009 | B1 |
7534263 | Burdulis, Jr. | May 2009 | B2 |
7618451 | Berez et al. | Nov 2009 | B2 |
7634119 | Tsougarakis et al. | Dec 2009 | B2 |
7717956 | Lang | May 2010 | B2 |
7792249 | Gertner | Sep 2010 | B2 |
7796791 | Tsougarakis et al. | Sep 2010 | B2 |
7799077 | Lang et al. | Sep 2010 | B2 |
7806896 | Bonutti | Oct 2010 | B1 |
7806897 | Bonutti | Oct 2010 | B1 |
7967868 | White et al. | Jun 2011 | B2 |
7981158 | Fitz | Jul 2011 | B2 |
8062302 | Lang et al. | Nov 2011 | B2 |
8066708 | Lang et al. | Nov 2011 | B2 |
8070752 | Metzger et al. | Dec 2011 | B2 |
8077950 | Tsougarakis et al. | Dec 2011 | B2 |
8083745 | Lang et al. | Dec 2011 | B2 |
8092465 | Metzger | Jan 2012 | B2 |
8094900 | Steines et al. | Jan 2012 | B2 |
8105330 | Fitz et al. | Jan 2012 | B2 |
8122582 | Burdulis, Jr. et al. | Feb 2012 | B2 |
8133234 | Meridew et al. | Mar 2012 | B2 |
8160345 | Pavlovskaia et al. | Apr 2012 | B2 |
8175683 | Roose | May 2012 | B2 |
8221430 | Park et al. | Jul 2012 | B2 |
8234097 | Steines et al. | Jul 2012 | B2 |
8241293 | Stone et al. | Aug 2012 | B2 |
8282646 | Schoenefeld et al. | Oct 2012 | B2 |
8298237 | Schoenefeld | Oct 2012 | B2 |
8337501 | Fitz et al. | Dec 2012 | B2 |
8337507 | Lang et al. | Dec 2012 | B2 |
8343218 | Lang et al. | Jan 2013 | B2 |
8366771 | Burdulis et al. | Feb 2013 | B2 |
8377129 | Fitz et al. | Feb 2013 | B2 |
8439926 | Bojarski et al. | May 2013 | B2 |
8460304 | Fitz et al. | Jun 2013 | B2 |
8480754 | Bojarski | Jul 2013 | B2 |
8500740 | Bojarski et al. | Aug 2013 | B2 |
8529568 | Bouadi | Sep 2013 | B2 |
8529630 | Bojarski | Sep 2013 | B2 |
8585708 | Fitz et al. | Sep 2013 | B2 |
8545569 | Fitz et al. | Oct 2013 | B2 |
8551099 | Lang | Oct 2013 | B2 |
8551102 | Fitz et al. | Oct 2013 | B2 |
8551103 | Fitz et al. | Oct 2013 | B2 |
8551169 | Fitz et al. | Oct 2013 | B2 |
8556906 | Fitz et al. | Oct 2013 | B2 |
8556907 | Fitz et al. | Oct 2013 | B2 |
8556971 | Lang | Oct 2013 | B2 |
8556983 | Bojarski | Oct 2013 | B2 |
8561278 | Fitz et al. | Oct 2013 | B2 |
8562611 | Fitz et al. | Oct 2013 | B2 |
8562618 | Fitz et al. | Oct 2013 | B2 |
8568479 | Fitz et al. | Oct 2013 | B2 |
8568480 | Fitz et al. | Oct 2013 | B2 |
8617172 | Fitz et al. | Dec 2013 | B2 |
8617242 | Philipp | Dec 2013 | B2 |
8623026 | Wong et al. | Jan 2014 | B2 |
8634617 | Tsougarakis et al. | Jan 2014 | B2 |
8638998 | Steines et al. | Jan 2014 | B2 |
8641716 | Fitz et al. | Feb 2014 | B2 |
8657827 | Fitz et al. | Feb 2014 | B2 |
8682052 | Fitz et al. | Mar 2014 | B2 |
8728168 | Hanssen | May 2014 | B2 |
8771365 | Bojarski | Jul 2014 | B2 |
20030055502 | Lang et al. | Mar 2003 | A1 |
20030176860 | Shimura | Sep 2003 | A1 |
20030216669 | Lang et al. | Nov 2003 | A1 |
20040068187 | Krause et al. | Apr 2004 | A1 |
20040133276 | Lang et al. | Jul 2004 | A1 |
20040138754 | Lang et al. | Jul 2004 | A1 |
20040147927 | Tsougarakis et al. | Jul 2004 | A1 |
20040153079 | Tsougarakis et al. | Aug 2004 | A1 |
20040204644 | Tsougarakis et al. | Oct 2004 | A1 |
20040204760 | Fitz et al. | Oct 2004 | A1 |
20040236424 | Berez et al. | Nov 2004 | A1 |
20050148843 | Roose | Jul 2005 | A1 |
20050234461 | Burdulis et al. | Oct 2005 | A1 |
20050267584 | Burdulis et al. | Dec 2005 | A1 |
20060111722 | Bouadi | May 2006 | A1 |
20070083266 | Lang | Apr 2007 | A1 |
20070100346 | Wyss | May 2007 | A1 |
20070100462 | Lang et al. | May 2007 | A1 |
20070156171 | Lang et al. | Jul 2007 | A1 |
20070157783 | Chiang | Jul 2007 | A1 |
20070173815 | Murase | Jul 2007 | A1 |
20070198022 | Lang | Aug 2007 | A1 |
20070226986 | Park et al. | Oct 2007 | A1 |
20070233141 | Park et al. | Oct 2007 | A1 |
20070233269 | Steines et al. | Oct 2007 | A1 |
20070250169 | Lang | Oct 2007 | A1 |
20070288030 | Metzger et al. | Dec 2007 | A1 |
20080114370 | Schoenefeld | May 2008 | A1 |
20080147072 | Park et al. | Jun 2008 | A1 |
20080161815 | Schoenefeld | Jul 2008 | A1 |
20080195216 | Philipp | Aug 2008 | A1 |
20080208200 | Crofford | Aug 2008 | A1 |
20080243127 | Lang | Oct 2008 | A1 |
20080269906 | Iannotti et al. | Oct 2008 | A1 |
20080275452 | Lang et al. | Nov 2008 | A1 |
20080281328 | Lang et al. | Nov 2008 | A1 |
20080281329 | Fitz et al. | Nov 2008 | A1 |
20080281426 | Fitz et al. | Nov 2008 | A1 |
20080287954 | Kunz | Nov 2008 | A1 |
20090018546 | Daley | Jan 2009 | A1 |
20090024131 | Metzgu et al. | Jan 2009 | A1 |
20090087276 | Rose | Apr 2009 | A1 |
20090088753 | Aram et al. | Apr 2009 | A1 |
20090088754 | Aker et al. | Apr 2009 | A1 |
20090088755 | Aker et al. | Apr 2009 | A1 |
20090088758 | Bennett | Apr 2009 | A1 |
20090088759 | Aram et al. | Apr 2009 | A1 |
20090088760 | Aram et al. | Apr 2009 | A1 |
20090088761 | Roose et al. | Apr 2009 | A1 |
20090088763 | Aram et al. | Apr 2009 | A1 |
20090093816 | Roose et al. | Apr 2009 | A1 |
20090099567 | Zajac | Apr 2009 | A1 |
20090110498 | Park et al. | Apr 2009 | A1 |
20090131941 | Park et al. | May 2009 | A1 |
20090131942 | Aker et al. | May 2009 | A1 |
20090138020 | Park et al. | May 2009 | A1 |
20090157083 | Park et al. | Jun 2009 | A1 |
20090163922 | Meridew et al. | Jun 2009 | A1 |
20090222014 | Bojarski | Sep 2009 | A1 |
20090222016 | Park | Sep 2009 | A1 |
20090222103 | Fitz et al. | Sep 2009 | A1 |
20090226068 | Fitz et al. | Sep 2009 | A1 |
20090228113 | Lang et al. | Sep 2009 | A1 |
20090254093 | White | Oct 2009 | A1 |
20090270868 | Park et al. | Oct 2009 | A1 |
20090276045 | Lang | Nov 2009 | A1 |
20090306676 | Lang et al. | Dec 2009 | A1 |
20090307893 | Burdulis, Jr. et al. | Dec 2009 | A1 |
20090312805 | Lang et al. | Dec 2009 | A1 |
20100023015 | Park | Jan 2010 | A1 |
20100042105 | Park et al. | Feb 2010 | A1 |
20100049195 | Park et al. | Feb 2010 | A1 |
20100054572 | Tsougarakis et al. | Mar 2010 | A1 |
20100082035 | Keefer | Apr 2010 | A1 |
20100087829 | Metzger et al. | Apr 2010 | A1 |
20100152741 | Park et al. | Jun 2010 | A1 |
20100152782 | Stone et al. | Jun 2010 | A1 |
20100160917 | Fitz et al. | Jun 2010 | A1 |
20100168754 | Fitz et al. | Jul 2010 | A1 |
20100174376 | Lang et al. | Jul 2010 | A1 |
20100185202 | Lester et al. | Jul 2010 | A1 |
20100191244 | White et al. | Jul 2010 | A1 |
20100212138 | Carroll et al. | Aug 2010 | A1 |
20100217270 | Polinski et al. | Aug 2010 | A1 |
20100217338 | Carroll et al. | Aug 2010 | A1 |
20100228257 | Bonutti | Sep 2010 | A1 |
20100234849 | Bouadi | Sep 2010 | A1 |
20100256479 | Park et al. | Oct 2010 | A1 |
20100262150 | Lian | Oct 2010 | A1 |
20100274534 | Steines et al. | Oct 2010 | A1 |
20100281678 | Burdulis, Jr. et al. | Nov 2010 | A1 |
20100286700 | Snider et al. | Nov 2010 | A1 |
20100298894 | Bojarski et al. | Nov 2010 | A1 |
20100303313 | Lang et al. | Dec 2010 | A1 |
20100303317 | Tsougarakis et al. | Dec 2010 | A1 |
20100303324 | Lang et al. | Dec 2010 | A1 |
20100305573 | Fitz et al. | Dec 2010 | A1 |
20100305574 | Fitz et al. | Dec 2010 | A1 |
20100305708 | Lang et al. | Dec 2010 | A1 |
20100305907 | Fitz et al. | Dec 2010 | A1 |
20100329530 | Lang et al. | Dec 2010 | A1 |
20110015636 | Katrana et al. | Jan 2011 | A1 |
20110015637 | De Smedt et al. | Jan 2011 | A1 |
20110015639 | Metzger et al. | Jan 2011 | A1 |
20110029091 | Bojarski et al. | Feb 2011 | A1 |
20110029093 | Bojarski et al. | Feb 2011 | A1 |
20110040168 | Arnaud et al. | Feb 2011 | A1 |
20110040303 | Iannotti | Feb 2011 | A1 |
20110054478 | Vanasse et al. | Mar 2011 | A1 |
20110060341 | Angibaud et al. | Mar 2011 | A1 |
20110066193 | Lang et al. | Mar 2011 | A1 |
20110066245 | Lang et al. | Mar 2011 | A1 |
20110066252 | Hanssen | Mar 2011 | A1 |
20110071533 | Metzger et al. | Mar 2011 | A1 |
20110071581 | Lang et al. | Mar 2011 | A1 |
20110071645 | Bojarski et al. | Mar 2011 | A1 |
20110071802 | Bojarski et al. | Mar 2011 | A1 |
20110087332 | Bojarski | Apr 2011 | A1 |
20110092977 | Salehi et al. | Apr 2011 | A1 |
20110093108 | Ashby et al. | Apr 2011 | A1 |
20110106093 | Romano et al. | May 2011 | A1 |
20110144760 | Wong et al. | Jun 2011 | A1 |
20110160736 | Meridew et al. | Jun 2011 | A1 |
20110160867 | Meridew et al. | Jun 2011 | A1 |
20110166578 | Stone et al. | Jul 2011 | A1 |
20110172672 | Dubeau et al. | Jul 2011 | A1 |
20110184419 | Meridew et al. | Jul 2011 | A1 |
20110190775 | Ure | Aug 2011 | A1 |
20110196377 | Hodorek et al. | Aug 2011 | A1 |
20110213368 | Fitz et al. | Sep 2011 | A1 |
20110213373 | Fitz et al. | Sep 2011 | A1 |
20110213374 | Fitz et al. | Sep 2011 | A1 |
20110213376 | Maxson et al. | Sep 2011 | A1 |
20110213377 | Lang et al. | Sep 2011 | A1 |
20110213427 | Fitz et al. | Sep 2011 | A1 |
20110213428 | Fitz et al. | Sep 2011 | A1 |
20110213429 | Lang et al. | Sep 2011 | A1 |
20110213430 | Lang et al. | Sep 2011 | A1 |
20110213431 | Fitz et al. | Sep 2011 | A1 |
20110214279 | Park et al. | Sep 2011 | A1 |
20110218539 | Fitz et al. | Sep 2011 | A1 |
20110218545 | Catanzarite et al. | Sep 2011 | A1 |
20110218584 | Fitz et al. | Sep 2011 | A1 |
20110224674 | White et al. | Sep 2011 | A1 |
20110230888 | Lang et al. | Sep 2011 | A1 |
20110238073 | Lang et al. | Sep 2011 | A1 |
20110245835 | Dodds et al. | Oct 2011 | A1 |
20110266265 | Lang | Nov 2011 | A1 |
20110295329 | Fitz et al. | Dec 2011 | A1 |
20110295378 | Bojarski | Dec 2011 | A1 |
20110313423 | Lang et al. | Dec 2011 | A1 |
20110313424 | Bono et al. | Dec 2011 | A1 |
20110319897 | Lang et al. | Dec 2011 | A1 |
20110319900 | Lang et al. | Dec 2011 | A1 |
20120010711 | Antonyshyn et al. | Jan 2012 | A1 |
20120029520 | Lang et al. | Feb 2012 | A1 |
20120041445 | Roose et al. | Feb 2012 | A1 |
20120041446 | Wong et al. | Feb 2012 | A1 |
20120065640 | Metzger et al. | Mar 2012 | A1 |
20120066892 | Lang et al. | Mar 2012 | A1 |
20120071881 | Lang et al. | Mar 2012 | A1 |
20120071882 | Lang et al. | Mar 2012 | A1 |
20120071883 | Lang et al. | Mar 2012 | A1 |
20120072185 | Lang et al. | Mar 2012 | A1 |
20120078254 | Ashby et al. | Mar 2012 | A1 |
20120078258 | Lo et al. | Mar 2012 | A1 |
20120078259 | Meridew | Mar 2012 | A1 |
20120093377 | Tsougarakis et al. | Apr 2012 | A1 |
20120101503 | Lang et al. | Apr 2012 | A1 |
20120109138 | Meridew et al. | May 2012 | A1 |
20120116203 | Vancraen et al. | May 2012 | A1 |
20120116562 | Agnihotri et al. | May 2012 | A1 |
20120123422 | Agnihotri et al. | May 2012 | A1 |
20120123423 | Fryman | May 2012 | A1 |
20120130382 | Iannotti | May 2012 | A1 |
20120130502 | Podolsky | May 2012 | A1 |
20120130687 | Otto et al. | May 2012 | A1 |
20120141034 | Iannotti et al. | Jun 2012 | A1 |
20120143197 | Lang et al. | Jun 2012 | A1 |
20120143198 | Boyer | Jun 2012 | A1 |
20120151730 | Fitz et al. | Jun 2012 | A1 |
20120158001 | Burdulis, Jr. et al. | Jun 2012 | A1 |
20120165820 | De Smedt et al. | Jun 2012 | A1 |
20120172884 | Zheng et al. | Jul 2012 | A1 |
20120191205 | Bojarski et al. | Jul 2012 | A1 |
20120191420 | Bojarski et al. | Jul 2012 | A1 |
20120192401 | Pavlovskaia et al. | Aug 2012 | A1 |
20120197260 | Fitz et al. | Aug 2012 | A1 |
20120197408 | Lang et al. | Aug 2012 | A1 |
20120201440 | Steines et al. | Aug 2012 | A1 |
20120209276 | Schuster | Aug 2012 | A1 |
20120209394 | Bojarski | Aug 2012 | A1 |
20120215226 | Bonutti | Aug 2012 | A1 |
20120221008 | Carroll et al. | Aug 2012 | A1 |
20120226283 | Meridew et al. | Sep 2012 | A1 |
20120232669 | Bojarski et al. | Sep 2012 | A1 |
20120232670 | Bojarski et al. | Sep 2012 | A1 |
20120232671 | Bojarski | Sep 2012 | A1 |
20120239045 | Li | Sep 2012 | A1 |
20120245647 | Kunz et al. | Sep 2012 | A1 |
20120245699 | Lang et al. | Sep 2012 | A1 |
20120265208 | Smith | Oct 2012 | A1 |
20120265496 | Mahfouz | Oct 2012 | A1 |
20120271366 | Katrana et al. | Oct 2012 | A1 |
20120276509 | Iannotti | Nov 2012 | A1 |
20120277751 | Catanzarite et al. | Nov 2012 | A1 |
20120289966 | Fitz et al. | Nov 2012 | A1 |
20120290272 | Bryan | Nov 2012 | A1 |
20120296337 | Fitz et al. | Nov 2012 | A1 |
20130018379 | Fitz et al. | Jan 2013 | A1 |
20130018380 | Fitz et al. | Jan 2013 | A1 |
20130018464 | Fitz et al. | Jan 2013 | A1 |
20130023884 | Fitz et al. | Jan 2013 | A1 |
20130024000 | Bojarski et al. | Jan 2013 | A1 |
20130030419 | Fitz | Jan 2013 | A1 |
20130030441 | Fitz et al. | Jan 2013 | A1 |
20130079781 | Fitz et al. | Mar 2013 | A1 |
20130079876 | Fitz et al. | Mar 2013 | A1 |
20130081247 | Fitz et al. | Apr 2013 | A1 |
20130096562 | Fitz et al. | Apr 2013 | A1 |
20130103363 | Lang et al. | Apr 2013 | A1 |
20130110471 | Lang et al. | May 2013 | A1 |
20130123792 | Fitz et al. | May 2013 | A1 |
20130184713 | Bojarski et al. | Jul 2013 | A1 |
20130197870 | Steines et al. | Aug 2013 | A1 |
20130211409 | Burdulis, Jr. et al. | Aug 2013 | A1 |
20130211410 | Landes et al. | Aug 2013 | A1 |
20130211531 | Steines | Aug 2013 | A1 |
20130245803 | Lang | Sep 2013 | A1 |
20130253522 | Bojarski et al. | Sep 2013 | A1 |
20130289570 | Chao | Oct 2013 | A1 |
20130296874 | Chao | Nov 2013 | A1 |
20130297031 | Hafez | Nov 2013 | A1 |
20130317511 | Bojarski et al. | Nov 2013 | A1 |
20130331850 | Bojarski et al. | Dec 2013 | A1 |
20140005792 | Lang et al. | Jan 2014 | A1 |
20140029814 | Fitz et al. | Jan 2014 | A1 |
20140031826 | Bojarski et al. | Jan 2014 | A1 |
20140039631 | Bojarski et al. | Feb 2014 | A1 |
20140058396 | Fitz et al. | Feb 2014 | A1 |
20140058397 | Fitz et al. | Feb 2014 | A1 |
20140066935 | Fitz et al. | Mar 2014 | A1 |
20140066936 | Fitz et al. | Mar 2014 | A1 |
20140074441 | Fitz et al. | Mar 2014 | A1 |
20140086780 | Miller et al. | Mar 2014 | A1 |
20140228860 | Steines | Aug 2014 | A1 |
20140343403 | Kunz | Nov 2014 | A1 |
Number | Date | Country |
---|---|---|
2004293091 | Jun 2005 | AU |
2004293104 | Jun 2005 | AU |
2005309692 | Jun 2006 | AU |
2005311558 | Jun 2006 | AU |
2002310193 | Mar 2007 | AU |
2006297137 | Apr 2007 | AU |
2002310193 | May 2007 | AU |
2007202573 | Jun 2007 | AU |
2007212033 | Aug 2007 | AU |
2007226924 | Sep 2007 | AU |
2009221773 | Sep 2009 | AU |
2009246474 | Nov 2009 | AU |
2010201200 | Apr 2010 | AU |
2011203237 | Jul 2011 | AU |
2010217903 | Sep 2011 | AU |
2010236263 | Nov 2011 | AU |
2010264466 | Feb 2012 | AU |
2010289706 | Mar 2012 | AU |
2010315099 | May 2012 | AU |
2010327987 | Jun 2012 | AU |
2011203237 | Oct 2012 | AU |
2012216829 | Oct 2012 | AU |
2012217654 | Oct 2013 | AU |
2007212033 | Jan 2014 | AU |
2014200073 | Jan 2014 | AU |
2012289973 | Mar 2014 | AU |
2012296556 | Mar 2014 | AU |
2501041 | Apr 2004 | CA |
2505371 | May 2004 | CA |
2505419 | Jun 2004 | CA |
2506849 | Jun 2004 | CA |
2546958 | Jun 2005 | CA |
2546965 | Jun 2005 | CA |
2804883 | Jun 2005 | CA |
2588907 | Jun 2006 | CA |
2590534 | Jun 2006 | CA |
2623834 | Apr 2007 | CA |
2641241 | Aug 2007 | CA |
2646288 | Sep 2007 | CA |
2717760 | Sep 2009 | CA |
2765499 | Dec 2010 | CA |
2771573 | Mar 2011 | CA |
2779283 | May 2011 | CA |
2782137 | Jun 2011 | CA |
2546965 | Mar 2013 | CA |
1728976 | Feb 2006 | CN |
1729483 | Feb 2006 | CN |
1729484 | Feb 2006 | CN |
1913844 | Feb 2007 | CN |
101111197 | Jan 2008 | CN |
101384230 | Mar 2009 | CN |
101442960 | May 2009 | CN |
100502808 | Jun 2009 | CN |
102006841 | Apr 2011 | CN |
102125448 | Jul 2011 | CN |
102405032 | Apr 2012 | CN |
102448394 | May 2012 | CN |
101420911 | Jul 2012 | CN |
102599960 | Jul 2012 | CN |
1913844 | Sep 2012 | CN |
102711670 | Oct 2012 | CN |
102724934 | Oct 2012 | CN |
102805677 | Dec 2012 | CN |
1729483 | Oct 2013 | CN |
103476363 | Dec 2013 | CN |
60336002 D1 | Mar 2011 | DE |
60239674 D1 | May 2011 | DE |
602004032166 D1 | May 2011 | DE |
602005027391 D1 | May 2011 | DE |
0558789 | Sep 1993 | EP |
1555962 | Jul 2005 | EP |
1558181 | Aug 2005 | EP |
1567985 | Aug 2005 | EP |
1575460 | Sep 2005 | EP |
1686930 | Aug 2006 | EP |
1686931 | Aug 2006 | EP |
1389980 | Apr 2007 | EP |
1814491 | Aug 2007 | EP |
1833387 | Sep 2007 | EP |
1686930 | Oct 2007 | EP |
1686931 | Jan 2008 | EP |
1928359 | Jun 2008 | EP |
1951136 | Aug 2008 | EP |
1981409 | Oct 2008 | EP |
1996121 | Dec 2008 | EP |
2114312 | Nov 2009 | EP |
2124764 | Dec 2009 | EP |
2 168 507 | Mar 2010 | EP |
1928359 | Oct 2010 | EP |
2259753 | Dec 2010 | EP |
2265199 | Dec 2010 | EP |
1555962 | Feb 2011 | EP |
2292188 | Mar 2011 | EP |
2292189 | Mar 2011 | EP |
1389980 | Apr 2011 | EP |
1686930 | Apr 2011 | EP |
1833387 | Apr 2011 | EP |
2303193 | Apr 2011 | EP |
2316357 | May 2011 | EP |
2324799 | May 2011 | EP |
2335654 | Jun 2011 | EP |
2403434 | Jan 2012 | EP |
2405865 | Jan 2012 | EP |
2419035 | Feb 2012 | EP |
2265199 | Mar 2012 | EP |
2303193 | Mar 2012 | EP |
2259753 | Apr 2012 | EP |
2292188 | May 2012 | EP |
2292189 | May 2012 | EP |
2445451 | May 2012 | EP |
2470126 | Jul 2012 | EP |
2496183 | Sep 2012 | EP |
2509539 | Oct 2012 | EP |
2512381 | Oct 2012 | EP |
2324799 | Jan 2013 | EP |
2419035 | Jan 2013 | EP |
2445451 | Mar 2013 | EP |
2403434 | Apr 2013 | EP |
2591756 | May 2013 | EP |
2496183 | Dec 2013 | EP |
2512381 | Dec 2013 | EP |
2649951 | Dec 2013 | EP |
2649951 | Dec 2013 | EP |
2671520 | Dec 2013 | EP |
2671521 | Dec 2013 | EP |
2671522 | Dec 2013 | EP |
2114312 | Jan 2014 | EP |
2710967 | Mar 2014 | EP |
2484042 | Mar 2012 | GB |
2489884 | Oct 2012 | GB |
201213674 | Oct 2012 | GB |
2484042 | Mar 2014 | GB |
1059882 | Aug 2011 | HK |
1072710 | Aug 2011 | HK |
1087324 | Nov 2011 | HK |
1104776 | Nov 2011 | HK |
2006510403 | Mar 2006 | JP |
2007514470 | Jun 2007 | JP |
2011519713 | Jul 2011 | JP |
2011224384 | Nov 2011 | JP |
2012091033 | May 2012 | JP |
2012176318 | Sep 2012 | JP |
5053515 | Oct 2012 | JP |
2012187415 | Oct 2012 | JP |
2012523897 | Oct 2012 | JP |
5074036 | Nov 2012 | JP |
2012531265 | Dec 2012 | JP |
2013503007 | Jan 2013 | JP |
5148284 | Feb 2013 | JP |
5198069 | May 2013 | JP |
2014000425 | Jan 2014 | JP |
20050072500 | Jul 2005 | KR |
20050084024 | Aug 2005 | KR |
20120090997 | Aug 2012 | KR |
20120102576 | Sep 2012 | KR |
2012007140 | Jan 2013 | MX |
597261 | Nov 2013 | NZ |
173840 | Sep 2011 | SG |
175229 | Nov 2011 | SG |
176833 | Jan 2012 | SG |
178836 | Apr 2012 | SG |
193484 | Oct 2013 | SG |
200509870 | Mar 2005 | TW |
1231755 | May 2005 | TW |
200800123 | Jan 2008 | TW |
1330075 | Sep 2010 | TW |
9325157 | Dec 1993 | WO |
2004049981 | Jun 2004 | WO |
2004051301 | Jun 2004 | WO |
2005051239 | Jun 2005 | WO |
2005051240 | Jun 2005 | WO |
2006058057 | Jun 2006 | WO |
2006060795 | Jun 2006 | WO |
2006058057 | Jul 2006 | WO |
2007041375 | Apr 2007 | WO |
2007062103 | May 2007 | WO |
2007092841 | Aug 2007 | WO |
2007109641 | Sep 2007 | WO |
2007092841 | Nov 2007 | WO |
2007109641 | Dec 2007 | WO |
2008101090 | Aug 2008 | WO |
2008109751 | Sep 2008 | WO |
2008112996 | Sep 2008 | WO |
2008101090 | Nov 2008 | WO |
2008157412 | Dec 2008 | WO |
2007041375 | Apr 2009 | WO |
2008157412 | Apr 2009 | WO |
2009111626 | Sep 2009 | WO |
2009111639 | Sep 2009 | WO |
2009111656 | Sep 2009 | WO |
2009140294 | Nov 2009 | WO |
2009111626 | Jan 2010 | WO |
2010099231 | Sep 2010 | WO |
2010099353 | Sep 2010 | WO |
2010121147 | Oct 2010 | WO |
2010099231 | Nov 2010 | WO |
2011028624 | Mar 2011 | WO |
2011056995 | May 2011 | WO |
2011072235 | Jun 2011 | WO |
2011075697 | Jun 2011 | WO |
2011056995 | Sep 2011 | WO |
2011075697 | Oct 2011 | WO |
2011072235 | Dec 2011 | WO |
2012112694 | Aug 2012 | WO |
2012112694 | Aug 2012 | WO |
2012112698 | Aug 2012 | WO |
2012112701 | Aug 2012 | WO |
2012112702 | Aug 2012 | WO |
2012112694 | Jan 2013 | WO |
2012112701 | Jan 2013 | WO |
2012112702 | Jan 2013 | WO |
2013020026 | Feb 2013 | WO |
2013025814 | Feb 2013 | WO |
2012112698 | Mar 2013 | WO |
2013056036 | Apr 2013 | WO |
2013119790 | Aug 2013 | WO |
2013119865 | Aug 2013 | WO |
2013131066 | Sep 2013 | WO |
2013152341 | Oct 2013 | WO |
2013155500 | Oct 2013 | WO |
2013155501 | Oct 2013 | WO |
2014008444 | Jan 2014 | WO |
2014035991 | Mar 2014 | WO |
2014047514 | Mar 2014 | WO |
Entry |
---|
Audenaert et al. (“A custom-made guide for femoral component positioning in hip resurfacing arthroplasty: development and validation study”, Informa UK Ltd, 2011, pp. 304-309) (Year: 2011). |
Gan et al. (“Novel patient-specific navigational template for total knee arthroplasty”, Informa UK Ltd, 2011, pp. 288-297) (Year: 2011). |
Murphy et al., “The Planning of Orthopaedic Reconstructive Surgery Using Computer-Aided Simulation and Design”, Camp. Med. /mag. and Graphics, 12:33-45, (1988). |
U.S. Iannotti et al., U.S. Appl. No. 61/408,324, filed Oct. 29, 2010, entitled “System and Method for Assisting with Attachment of a Stock Implant to a Patient Tissue”. |
U.S. Iannotti et al., U.S. Appl. No. 61/408,359, filed Oct. 29, 2010, entitled “System and Method for Association of a Guiding Aid with a Patient”. |
U.S. Iannotti et al., U.S. Appl. No. 61/408,376, filed Oct. 29, 2010, entitled “System and Method for Assisting with Arrangement of a Stock Instrument with Respect to a Patient Tissue”. |
International Search Report and Written Opinion for PCT/US2011/057957, dated Apr. 18, 2012, pp. 1-11. |
Krekel, et al., Interactive Simulation and Comparative Visualisation of the . . . , Data Visualisation Group, Delft Univ. of Technology, pp. 1-13. |
Krekel, et al., Combined Surface and Volume Processing for Fused Joint Segmentation, Springer Int'l. Journal of Computer Assisted Radiology and Surgery, pp. 1-24. |
Krekel, et al., Visual Analysis of Multi-Joint Kinematic Data, Eurographics/IEEE-VGTC Symposium on Visulatization 2010, vol. 29 (2010), No. 3, pp. 1-10. |
Krekel, et al., Evaluation of Bone Impingement Prediction in Preoperative Planning for Shoulder Arthroplasty, Proc. I MechE vol. 223, Part H: J.Engin. in Med., 2009, pp. 1-10. |
Botha, et al., Pre-Operative Planning and Intra-Operative Guidance for Shoulder Replacement Surgery, Dagstuhl Publ., pp. 179-195. Ylftekhar. |
Taylor et al, “Computer-Integrated Surgery, Technology and Clinical Applications”, The MIT Press, Cambridge, MA, London, UK, pp. 451-463. |
Hofmann et al, “Natural-Knee II System”, Intermedics Orthopedics, Austin, TX, 1995. |
Number | Date | Country | |
---|---|---|---|
20170296205 A1 | Oct 2017 | US |
Number | Date | Country | |
---|---|---|---|
61408392 | Oct 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13282550 | Oct 2011 | US |
Child | 15642424 | US |